Method for treating rosacea using oral or topical ivermectin
US5952372A · kind A · utility
59Cited by
0References
9Claims
0Family size
Inventor
Key dates
| Filing date | Sep 17, 1998 |
| Grant date | Sep 14, 1999 |
| Priority date | — |
| Expiry date | Sep 17, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/35
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating rosacea in humans involving orally-administered or topically-applied ivermectin is disclosed. More specifically, oral ivermectin in a regimen of 200 micrograms per kilogram body weight per dose for 2 or 3 consecutive doses at least 3 and not more than 7 days apart as the preferred regimen or, alternatively, topical ivermectin compounded to a 2% concentration by weight in a cream, lotion, or gel carrier vehicle is administered as an effective treatment for all clinical stages and signs of rosacea in affected persons.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.